2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

2.44 PHARMSYNTHEZ
Company profile
Pharmsynthez is a Russian pharmaceutical company specializing
in the production and promotion of portfolio for innovative
medicines. The company can operate in three directions at once,
which is unique for the Russian pharmaceutical market:
laboratory research and development of new medicaments,
manufacturing of original substances and medicaments and their
market launch.
A unique specialization in production and promotion of a
portfolio of innovative medicines, as well as the ability to carry
out R&D contracts distinguish Pharmsynthez among Russian
biopharmaceutical manufacturers.
Shareholders and management of the company successfully
develop technologically complicated business with a focus on
their own unique, innovative products and see significant
perspectives both in the fast-growing pharmaceutical markets of
Russia, the CIS, the EU and the USA.
Products and services
The company produces original and generic drugs to combat the
following groups of diseases:
§ Tumors;
§ Glaucoma;
§ Tuberculosis and others.
Key figures:
Founded: 23.08.1999
Turnover (2020): 200,321 mln. RUB
Employees (2020): 80
INN: 7801075160
Type of company: medium-sized enterprise
Product code: 21.20.1 Manufacturing of
pharmaceuticals
Contact information:
Kapitolovo station 134 lit. 1
Kuzmolovskii, Vsevolozhskii district
188663 Leningrad region, Russia
+7 (812) 329 80 80
info@pharmsynthez.com
http://pharmsynthez.com/
Contact person: Prilezhaev Efim – General
director
132
RUSSIAN-FINNISH LIFE SCIENCE INDUSTRY
Research and export directory